CI Investments Inc’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,754
Closed -$48K 1319
2023
Q3
$48K Sell
5,754
-172
-3% -$1.85K ﹤0.01% 974
2023
Q2
$74K Buy
5,926
+3,032
+105% +$37.7K ﹤0.01% 862
2023
Q1
$48K Sell
2,894
-38
-1% -$681 ﹤0.01% 910
2022
Q4
$44K Buy
+2,932
New +$56.1K ﹤0.01% 961

Other funds holding RLAY

CI Investments Inc's RLAY Position: Q4 2023 in Review

CI Investments Inc sold out of Relay Therapeutics (RLAY) in Q4 2023, closing a stake of 5,754 shares — an estimated $48K sold.

CI Investments Inc first reported a position in RLAY in Q4 2022 and held it in 4 quarters. The position peaked at $74K in Q2 2023. 177 funds tracked by Wall St. Rank hold RLAY as of Q4 2023.

  • CI Investments Inc reported no remaining Relay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • CI Investments Inc sold 5,754 Relay Therapeutics shares in Q4 2023, an estimated $48K.
  • CI Investments Inc first reported a position in Relay Therapeutics in Q4 2022 and held it in 4 quarters.
  • CI Investments Inc's Relay Therapeutics position peaked at $74K in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2023.

Based on CI Investments Inc's 13F filing for Q4 2023, filed 12 Feb 2024.